PLXPQ — PLx Pharma Winddown Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$9.82m
- $8.21m
PLx Pharma: Rises as FDA approves Vazalore in two dose strengths
Brief: Plx Pharma Inc Files Prospectus Related To Resale Of Up To About 10 Mln Shares Of Co's Common Stock
Brief: Plx Pharma Inc. Reports Third Quarter 2020 Results And Provides Business Update
Brief: Plx Pharma Says Co Entered Into Securities Purchase Agreement
Brief: Plx Pharma Submits Supplemental New Drug Applications For Vazalore To U.S. FDA
Brief: PLx Pharma Q2 Loss Per Share $0.66
Brief: Plx Pharma Inc Files For Shelf Of Up To 2.6 Million Shares By Selling Stockholders - SEC Filing
Brief: Plx Pharma Inc - On April 28, 2020, Co Received Written Notice From Listing Qualifications Department Of Nasdaq
NASDAQ RESUMED AT 10:11 AM
Brief: PLX Pharma Reports Q4 Loss Per Share Of $0.25
Brief: PLx Pharma Provides Regulatory Update On Vazalore
NASDAQ RESUMED
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
NASDAQ RESUMED
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
Brief: PLX Pharma Q3 Earnings Per Share $0.09
NASDAQ RESUMED
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
NASDAQ RESUMED